Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

By Dancey Janet E.  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1125-1138

Adis International

Access to resources Recommend Favorite

The potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer

By Gridelli Cesare   Rossi Antonio   Bareschino Maria Anna   Schettino Clorinda   Sacco Paola Claudia   Maione Paolo  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 631-639

Informa Healthcare

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

By  

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 818-832

Bentham Science Publishers

Access to resources Recommend Favorite

Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 851-864

Bentham Science Publishers

Access to resources Recommend Favorite

Optimal Management of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations

By Lin Chia-Chi   Yang James Chih-Hsin  

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 79-88

Adis International

Access to resources Recommend Favorite